NCT05447663 A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant Status TERMINATED Phase PHASE1/PHASE2
NCT05445843 Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05440942 Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE1
NCT05440487 Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload Status COMPLETED Phase N/A
NCT05432388 Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts Status COMPLETED Phase PHASE2
NCT05429502 Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors Status TERMINATED Phase PHASE1
NCT05424523 Effectiveness and Safety of Omalizumab in Children With Allergic Asthma. Status COMPLETED Phase N/A
NCT05421104 Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea. Status COMPLETED Phase N/A
NCT05415072 A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05413980 Effectiveness and Safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative Sterilization in Patients Undergoing Ophthalmic Surgery Status COMPLETED Phase N/A
NCT05399992 Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05397496 Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05388916 A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China Status COMPLETED Phase N/A
NCT05386680 Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam Status COMPLETED Phase PHASE3
NCT05384587 Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05380453 Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission Status COMPLETED Phase PHASE3
NCT05376579 Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy Status COMPLETED Phase N/A
NCT05375097 Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities. Status COMPLETED Phase N/A
NCT05368818 An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source Status COMPLETED Phase N/A